These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1977841)

  • 1. Effect of sodium depletion on active renin, inactive renin and prekallikrein in plasma and urinary kallikrein excretion in glomerulonephritic patients.
    Tsai TJ; Chen WY; Yen TS
    J Formos Med Assoc; 1990 May; 89(5):341-5. PubMed ID: 1977841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium depletion on urinary excretion of active and inactive kallikrein in glomerulonephritic patients.
    Tsai TJ; Chen YM; Yeah FT; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jan; 90(1):105-8. PubMed ID: 1679103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of active and inactive plasma renin and changes in urinary kallikrein and plasma prekallikrein to various conditions in normal subjects.
    Nakamaru M; Ogihara T; Higaki J; Hata T; Ohde H; Naka T; Masuo K; Gotoh S; Kumahara Y; Murakami K
    J Clin Endocrinol Metab; 1982 Apr; 54(4):682-8. PubMed ID: 7037811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma active renin, inactive renin and kallikrein in patients with disseminated intravascular coagulation.
    Lai HS; Tsai TJ; Chen YM; Wu KD; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 May; 90(5):448-51. PubMed ID: 1680981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma active and inactive renin and prekallikrein during hemodialysis.
    Tsai TJ; Wu CY; Chen YM; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Sep; 90(9):871-3. PubMed ID: 1683391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma renin and kallikrein in parturient women and newborn babies.
    Tsai TJ; Sheih CP; Chen YM; Hsieh BS
    J Formos Med Assoc; 1991 Jul; 90(7):645-51. PubMed ID: 1681014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
    Wong PY; Talamo RC; Williams GH; Colman RW
    J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal variation in water, sodium and potassium excretion in primary glomerulonephritic patients and its relation to diurnal kallikrein excretion.
    Chen YM; Tsai TJ; Chang PI; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1990 Dec; 89(12):1052-6. PubMed ID: 1982672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat.
    Gilboa N; Rudofsky UH; Phillips MI; Magro AM
    Nephron; 1989; 51(1):61-6. PubMed ID: 2644567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of inactive plasma renin by plasma and tissue kallikreins.
    Derkx FH; Tan-Tjiong HL; Man in 't Veld AJ; Schalekamp MP; Schalekamp MA
    Clin Sci (Lond); 1979 Oct; 57(4):351-7. PubMed ID: 41667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB; Lilley JJ; Frigon RP; Stone RA
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alterations in sodium and water metabolism on urinary excretion of active and inactive kallikrein in man.
    Lieberthal W; Oza NB; Arbeit L; Bernard DB; Levinsky NG
    J Clin Endocrinol Metab; 1983 Mar; 56(3):513-9. PubMed ID: 6549759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI; Matthews PG; Dax E
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium and angiotensin II on urinary active and inactive kallikrein in rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Omata K; Kasai Y; Kudo K; Tsunoda K; Sato M; Chiba S
    J Hypertens; 1986 Feb; 4(1):13-8. PubMed ID: 3633948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of rat urinary and renal kallikrein and prekallikrein by corticosteroids.
    Noda Y; Yamada K; Igic R; Erdös EG
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3059-63. PubMed ID: 6344076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.